What Is DTC in Healthcare? Pharma, Devices, Telehealth, and Direct-to-Patient

"DTC" gets used loosely in healthcare meetings. A pharma brand lead means a TV spot and a streaming plan. A device marketer means a lead generation funnel for a hearing aid or a glucose monitor. A telehealth founder means a subscription business with a paid social engine. These are related, but they live under different regulators and carry different risks.

This piece sorts them out so you can tell which rulebook applies to the work in front of you. For how the pharma version works end to end, see the DTC pharma marketing guide.

What is DTC in healthcare, in one definition

Direct-to-consumer healthcare is any communication or service that goes from a manufacturer, provider, or health company straight to the patient, without a clinician acting as the gatekeeper for the message. The patient may still need a clinician for the product (a prescription, a fitting, a diagnosis). What makes it DTC is who the message is addressed to.

The opposite track is HCP marketing, aimed at prescribers and other clinicians. Most pharma brands run both. The differences are covered in HCP vs. DTC marketing.

The four main kinds of healthcare DTC

Prescription drug DTC

This is the version most people picture. FDA regulates it under 21 CFR Part 202, which requires fair balance between benefit and risk, consistency with the approved label, and either a brief summary (print) or a major statement plus adequate provision (broadcast). Ads come in three types: product claim, reminder, and help-seeking. Unbranded disease awareness ads are not product advertising, but they still get careful review because they can become promotional if paired too closely with branded material.

Medical device DTC

Device advertising splits by classification. FDA has advertising authority over restricted devices, and the FTC handles advertising for most other devices. In practice this means a consumer device brand may run under rules closer to general consumer advertising, with the FTC's standard that claims be truthful and backed by competent evidence. Programmatic and paid social look similar to pharma, but the creative usually has more freedom. More on that in programmatic advertising for medical device marketing.

Telehealth DTC

Telehealth companies advertise a service: talk to a clinician, get evaluated, possibly get a prescription. Their ads are mainly governed by the FTC and state consumer protection law. Things get more complicated when the ad features a specific prescription drug, because then the ad starts to look like drug promotion. Privacy is the other big issue. Intake flows collect symptoms and conditions, and tracking pixels on those pages have drawn regulatory attention from both HHS (for HIPAA covered entities) and the FTC (for companies outside HIPAA, under the Health Breach Notification Rule and its general authority).

Direct-to-patient programs

Direct-to-patient, or DTP, is a manufacturer offering a path from the brand to care. A patient lands on a manufacturer platform, gets connected to an independent telehealth provider, and if prescribed, gets the drug through a pharmacy partner, sometimes at a cash price. Several large manufacturers launched these in 2024. DTP is not an ad format. It is a destination, and it changes how DTC media is planned and measured. See what direct-to-patient programs change for media.

How the rules differ in practice

The cleanest way to think about it: the regulator follows the product and the claim, and the privacy rules follow the data.

• If the ad makes a claim about a prescription drug, assume FDA promotional rules apply regardless of who paid for the media.
• If the ad promotes a service or a non-restricted device, FTC standards on truthful advertising and substantiation are the main frame.
• If the business is a HIPAA covered entity (a health system, many telehealth providers), HHS guidance on online tracking technologies matters for pixels and site analytics.
• If the business is not covered by HIPAA but handles health data from consumers, the FTC Health Breach Notification Rule and state consumer health data laws are the likely frame.

None of this is legal advice, and the edges are contested. A telehealth brand that only sells one compounded product, for example, sits in a gray zone that regulators have been looking at closely.

What "DTC perspectives" usually means

People searching "DTC perspectives" are often looking for industry commentary on where DTC is heading: the shift from linear to streaming, the growth of DTP platforms, and the regulatory pressure on drug ads that intensified in September 2025. The useful perspective for a practitioner is narrower. Ask which of the four DTC types your program really is, because that answer decides your review process, your audience options, and your measurement design.

Where teams get the category wrong

The most frequent mistake I see is a pharma team borrowing a telehealth growth playbook (aggressive retargeting, conversion pixels on every page, lookalike audiences seeded from intake data) without noticing the rules are different. The second is a device or telehealth team assuming FDA rules never touch them, then running an ad that names a prescription drug. Both are fixable early and expensive to fix late.

Practical takeaway

For your current program, write down in one line which of the four DTC types it is, which regulator owns the ad claims, and which privacy regime governs the data your media will use. Share that line with legal and your media partner before the next brief, so everyone is planning under the same rulebook.

Frequently asked questions

What does DTC stand for in healthcare?

DTC stands for direct-to-consumer. In healthcare it describes marketing or services aimed at patients and the public rather than at clinicians, and it covers prescription drug ads, device marketing, telehealth services, and manufacturer direct-to-patient programs.

Is DTC the same as DTP?

No. DTC usually refers to advertising and communication with consumers. DTP, or direct-to-patient, refers to a manufacturer or partner providing a path to care or fulfillment, such as telehealth prescribing and pharmacy delivery. A DTP program often relies on DTC advertising to drive traffic.

Who regulates DTC advertising for medical devices?

For restricted devices, FDA has authority over advertising. For most other devices, the FTC has primary authority over advertising, while FDA regulates labeling. Check the classification of the specific device with regulatory counsel.

Do telehealth companies follow the same rules as drug makers?

Not exactly. A telehealth company advertising its service is mainly under FTC and state rules, but if its ads promote a specific prescription drug on behalf of or in coordination with a manufacturer, FDA rules can come into play. Privacy rules also differ depending on whether the company is a HIPAA covered entity.

Sources

• FDA, Basics of Drug Ads
• eCFR, 21 CFR Part 202 Prescription Drug Advertising
• FTC, Health Breach Notification Rule: The Basics for Business
• HHS, Use of Online Tracking Technologies by HIPAA Covered Entities and Business Associates

External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.